ALFA Finder| Revenue growth | FY26 revenue up 16% YoY, crossing the ₹25,000 crore milestone. |
|---|---|
| Margins | Healthcare margins steady at 23.9%; established hospitals improved to 25.5%. |
| Demand visibility | Strong domestic surgical demand; international patient volumes show slight moderation. |
| Management confidence | High; emphasizing structural shifts in high-acuity surgical volumes and digital scale. |
Growth
Growth was balanced with 7% volume, 5% case mix, and 4% pricing improvements; specialized oncology and cardiac revenues rose 22%.
Outlook
Projecting ₹25,000 crore Healthco run-rate and digital break-even including ESOPs by Q4FY27.
Risks
Expansion drag from 1,400 new beds and international patient moderation from Bangladesh remain key headwinds for margins.
Earnings Call filed with NSE, NSE: APOLLOHOSP. Summary written with AI assistance from the document.
Apollo Hospitals Enterprise Ltd: key numbers
- Share price
- ₹8,502.00
- Market cap
- ₹1,22,246 Cr
- Revenue (annual)
- ₹25,228 Cr
- Net profit (annual)
- ₹1,942 Cr
- P/E (TTM)
- 54.5×Sector 54.5×
- Promoter holding
- 28.02%+0.00% QoQ
- FII holding
- 43.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Apollo Hospitals Enterprise Ltd
All →Apollo Hospitals Enterprise Earnings Call Transcript: Key Takeaways
Consolidated Q2 revenue ₹7,615 Cr (+23%), EBITDA ₹1,191 Cr (+29%), margin 15.6% vs 14.9%. Growth is solid, but Apollo Health Co's FY27 margin outlook was trimmed and management avoided explicit hospital growth guidance.
Apollo Hospitals Enterprise Investor Presentation: Key Takeaways
Q2 FY27 consolidated revenue ₹76,149 mn (+23%), EBITDA ₹11,910 mn (+29%), PAT ₹6,301 mn (+32%). Demerger and hospital expansion continue.
Apollo Hospitals Enterprise Q2 FY27 Results: Net Profit ₹659.5 Cr, Up 33.5% YoY
Apollo Hospitals Enterprise Ltd reported revenue from operations of ₹7,615 Cr (+23.0% YoY) and net profit of ₹659.5 Cr (+33.5% YoY) for Q2 FY27.
- Key figure
- Net profit ₹659.5 Cr · +33.5% YoY
Apollo Hospitals Enterprise Board Meeting Date
Apollo Hospitals will hold a board meeting on 04 Nov 2026 to consider Q1 FY27 financial results. No financial figures are disclosed in this advance intimation.
Apollo Hospitals Enterprise Other Announcement
Apollo Hospitals Enterprise Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026, as per regulatory requirements.
Apollo Hospitals Enterprise Share Pledge
Apollo Hospitals Enterprise promoter K Vishweshwar Reddy created a pledge on 200,000 equity shares worth ₹177.78 Crore. This transaction reflects a change in promoter encumbrance status.
- Value
- ₹177.8 Cr